For most people, a fever or a minor surgery is a temporary inconvenience. But for individuals with adrenal insufficiency or those taking long-term corticosteroids, these physical stressors can quickly become life-threatening. A stress dose of steroids is a critical medical intervention designed to mimic the body’s natural response to illness and trauma. Without this crucial adjustment in medication, patients are at serious risk of an adrenal crisis—a severe and potentially fatal condition. In this article, we examine the medical definition of stress dosing, the patient populations who require it, and the standard clinical guidelines that keep vulnerable patients safe during physiologically stressful events.

What Is a Stress Dose of Steroids? Medical Definition

A stress dose of steroids refers to the deliberate administration of supplemental glucocorticoids—typically hydrocortisone—at doses that exceed a patient’s normal daily replacement regimen, with the explicit purpose of replicating the physiological cortisol surge that a healthy hypothalamic-pituitary-adrenal (HPA) axis would generate in response to significant physical stress. In clinical practice, this intervention is prescribed and managed by endocrinologists, primary care physicians, and emergency medicine specialists for patients whose adrenal glands cannot mount an adequate cortisol response on their own.

The term is used across multiple clinical settings: from a patient at home doubling their oral hydrocortisone during a bout of influenza, to an anesthesiologist administering intravenous hydrocortisone to a surgical patient with known secondary adrenal insufficiency. The underlying pharmacological rationale is identical in all cases—ensuring that circulating glucocorticoid levels remain sufficient to support cardiovascular stability, immune modulation, and metabolic homeostasis during periods of elevated physiological demand.

The Body’s Normal Cortisol Response to Stress

Under normal circumstances, the body regulates cortisol output through the HPA axis. When the hypothalamus detects a threat—be it infection, hemorrhage, surgical trauma, or severe pain—it releases corticotropin-releasing hormone (CRH), which signals the anterior pituitary to secrete adrenocorticotropic hormone (ACTH). ACTH then acts on the adrenal cortex, driving a rapid and robust increase in cortisol production. Basal cortisol secretion in healthy adults typically ranges from approximately 8–25 mcg/dL, but during severe physiological stress, plasma cortisol can rise to 75–150 mcg/dL or higher. This surge serves multiple survival functions: it mobilizes glucose through hepatic gluconeogenesis, enhances vascular reactivity to catecholamines (stabilizing blood pressure), and modulates the inflammatory response to prevent harmful immunological overshoot.

This finely calibrated system operates autonomously in people with intact adrenal function. The concern arises when the adrenal glands, the pituitary, or the hypothalamus—any node of the HPA axis—are compromised, leaving the body biochemically unable to generate the cortisol surge that a stressful event demands. The Endocrine Society guidelines provide detailed frameworks for managing this cortisol deficiency in a standardized, evidence-based manner.

Why Supplemental Steroids Are Necessary

When the HPA axis is suppressed or destroyed, the adrenal glands fail to respond to ACTH stimulation. The resulting glucocorticoid deficiency produces a clinical picture characterized by hypotension, profound fatigue, nausea, vomiting, hyponatremia, and in severe cases, vascular collapse and death. Exogenous glucocorticoids—administered on a “stress dose” schedule—effectively substitute for the cortisol that the adrenal cortex cannot produce. This is not a pharmacological enhancement or a performance-related application of steroids; it is strict physiological replacement therapy calibrated to biological need. Evidence from clinical outcome studies consistently demonstrates that patients who follow stress dosing protocols have significantly better outcomes during acute illness, surgery, and other physiological challenges than those who maintain their usual replacement dose unchanged.

Healthcare professional in blue gloves preparing an IV hydrocortisone infusion in a modern hospital room for a patient with adrenal insufficiency

Who Needs Stress Dose Corticosteroids?

Not every patient on steroid therapy requires a stress dose during illness or surgery. The need is determined by the degree to which the HPA axis is suppressed and whether the patient can mount a physiologically adequate cortisol response independently. Three major clinical populations are reliably identified in the medical literature as requiring stress dosing protocols.

Primary Adrenal Insufficiency (Addison’s Disease)

Patients with primary adrenal insufficiency, commonly called Addison’s disease, have experienced destruction or dysfunction of the adrenal cortex itself—through autoimmune attack, infection (such as tuberculosis), hemorrhage, or surgical removal. These individuals produce no endogenous cortisol whatsoever and are entirely dependent on exogenous glucocorticoid replacement at all times. Their daily regimen typically consists of two to three divided doses of hydrocortisone (usually 15–25 mg/day total) to mimic the natural diurnal cortisol rhythm. Because their adrenal glands cannot augment output in response to physiological demand, any significant physical stressor—fever, gastroenteritis, dental surgery, or trauma—poses an immediate, life-threatening risk of adrenal crisis. The National Institute of Diabetes and Digestive and Kidney Diseases classifies this population as the highest-priority group for rigorous stress dosing education and emergency injection preparedness.

Secondary and Tertiary Adrenal Insufficiency

Secondary adrenal insufficiency results from pituitary pathology—most commonly a pituitary adenoma, surgical resection, Sheehan’s syndrome, or traumatic brain injury—that reduces or eliminates ACTH secretion. Without adequate ACTH stimulation, the adrenal cortex atrophies and loses its capacity to produce cortisol, even though the gland tissue itself may be intact. Tertiary adrenal insufficiency arises from hypothalamic dysfunction that reduces CRH output, most often as a consequence of prolonged exogenous glucocorticoid therapy that suppresses the hypothalamus through negative feedback. In both scenarios, the adrenal response to physiological stress is blunted or absent, and stress dosing is required during acute illness and surgery. The degree of HPA suppression—and thus the clinical threshold for stress dosing—must be assessed individually, typically using low-dose ACTH (cosyntropin) stimulation testing.

Patients on Chronic Glucocorticoid Therapy

This population is numerically the largest. Individuals who have been taking supraphysiologic doses of glucocorticoids (prednisone ≥5 mg/day, or the equivalent, for more than three to four weeks) are at significant risk of iatrogenic HPA axis suppression—a state of glucocorticoid dependency where the hypothalamus and pituitary have downregulated their own signaling because exogenous glucocorticoids have chronically satisfied the feedback loop. Common clinical scenarios include patients on long-term corticosteroid therapy for rheumatoid arthritis, asthma, inflammatory bowel disease, organ transplantation, and dermatological conditions. The degree of suppression is dose- and duration-dependent and varies considerably between individuals, which is why perioperative assessment and individualized stress dosing plans—rather than blanket protocols—are increasingly recommended in the literature on perioperative steroid management.

Common Triggers Requiring a Stress Dose

The physiological threshold for initiating a stress dose is not based on the patient’s subjective perception of stress, but rather on objective markers of tissue injury, infection, hemodynamic instability, or metabolic demand. The following categories represent the most clinically well-established triggers, as recognized by endocrinology consensus bodies and emergency medicine guidelines.

Illness, Fever, and Infections

Febrile illness is the most common trigger prompting patients to apply the “sick day rules.” When body temperature rises above 38°C (100.4°F), or when any moderate illness causes significant malaise, vomiting, diarrhea, or inability to eat, the cortisol demand increases substantially. Clinical guidance across multiple professional organizations generally recommends doubling or tripling the usual oral hydrocortisone or prednisone dose at the onset of illness, continuing the elevated dose until the illness resolves and normal function returns. Upper respiratory infections, influenza, urinary tract infections, and gastrointestinal illnesses are among the most frequent precipitants. A particularly dangerous scenario arises when vomiting prevents the patient from absorbing oral medication—a situation that mandates intramuscular or intravenous hydrocortisone injection and typically emergency medical evaluation. Severe sepsis, while at the extreme end of this spectrum, represents an absolute emergency requiring immediate parenteral glucocorticoids, vasopressors, and intensive care-level management.

Surgery, Anesthesia, and Dental Procedures

Surgical procedures—including dental extractions under general or local anesthesia—represent predictable physiological stressors for which stress dosing can be planned proactively in coordination with the surgical and anesthetic teams. The magnitude of the required stress dose is proportional to the severity of the procedure. Minor procedures under local anesthesia (such as a simple dental filling) generally require only the patient’s usual morning dose. Moderate procedures (laparoscopic surgery, colonoscopy under sedation) typically require 50–75 mg of hydrocortisone equivalent on the day of the procedure. Major surgical procedures (open abdominal surgery, cardiac surgery, orthopedic reconstruction) may require 100–150 mg hydrocortisone equivalent per day for 24–48 hours, followed by a rapid taper back to the patient’s maintenance dose over two to three days as the physiological stress resolves. These stratified protocols reflect the understanding that both under-treatment (adrenal crisis) and over-treatment (hyperglycemia, delayed wound healing, immunosuppression) carry clinical risks.

Trauma and Severe Injuries

Accidental trauma—fractures, burns, crush injuries, or significant blood loss—activates the HPA axis maximally in individuals with intact adrenal function. In adrenal-insufficient patients, the same injuries precipitate immediate cortisol deficiency that compounds the hemodynamic instability already caused by the injury itself. For this reason, patients with documented adrenal insufficiency are advised to wear medical alert identification (bracelets or cards) that communicates their diagnosis, their usual steroid medication, and instructions for emergency personnel to administer hydrocortisone 100 mg intramuscularly or intravenously in the event the patient is unconscious or unable to self-administer. Major trauma is treated analogously to major surgery in terms of glucocorticoid supplementation requirements.

General Guidelines for Stress Dosing

Stress dosing protocols are individualized and should always be developed in consultation with a treating endocrinologist or physician. However, widely used frameworks exist that provide a rational starting point for patients and caregivers. The following guidelines reflect consensus positions from major endocrinology bodies, adapted for clarity.

The “Sick Day Rules” for Oral Medication

The sick day rules are a set of practical instructions given to patients with adrenal insufficiency—and often those on long-term corticosteroid therapy—to self-manage their glucocorticoid dosage during illness. The general principles, which may be adapted by individual physicians based on patient-specific factors, are as follows:

  • Mild illness (low-grade fever, cold symptoms, general malaise): Double the usual daily oral hydrocortisone or prednisone dose. Divide into the same number of doses as normal, administered throughout the day.
  • Moderate illness (fever above 38.5°C, significant fatigue, vomiting beginning): Triple the usual daily dose. Take doses every six to eight hours. Seek medical evaluation if condition worsens or does not improve within 24 hours.
  • Severe illness, vomiting, or inability to swallow: Administer injectable hydrocortisone (typically 100 mg intramuscularly) immediately. Call emergency services. Do not attempt to continue oral medication if it cannot be reliably absorbed.
  • Recovery: Return to the usual maintenance dose within two to three days of clinical improvement. Prolonged stress dosing beyond the period of physiological need carries the risk of adrenal suppression in its own right and other glucocorticoid-related adverse effects.

Patients and their immediate family members or caregivers should receive explicit training in applying these rules and should have a written emergency action plan—often called an “adrenal crisis action plan”—provided by their endocrinologist.

Intramuscular (IM) and Intravenous (IV) Administration

When oral administration is not feasible—due to vomiting, loss of consciousness, surgical NPO (nil per os) requirements, or rapid clinical deterioration—parenteral hydrocortisone is the standard of care. Hydrocortisone sodium succinate (the water-soluble, injectable form) is used in both intramuscular and intravenous settings. In an acute community setting, patients with adrenal insufficiency are typically prescribed an emergency hydrocortisone auto-injector or vial-and-syringe kit, with clear instructions for self-injection or caregiver injection into the outer thigh or buttock. For hospital-based administration, hydrocortisone 100 mg IV bolus is the standard initial dose for suspected adrenal crisis, followed by a continuous IV infusion of 200 mg over 24 hours or equivalent divided doses, depending on clinical protocols. Saline resuscitation is administered concurrently to correct hypovolemia and hyponatremia.

Symptoms of Adrenal Crisis: When to Act Immediately

An adrenal crisis—also called acute adrenocortical insufficiency—is a medical emergency with a mortality rate that can approach 6% even with modern treatment, and significantly higher if unrecognized or treatment is delayed. It occurs when cortisol levels fall below the threshold required to maintain basic physiological function, typically in a context where demand has acutely increased (illness, trauma, or surgery) and the physiological reserve has been exhausted.

Recognizing Severe Cortisol Deficiency

The clinical presentation of adrenal crisis spans a spectrum from non-specific prodromal symptoms to acute cardiovascular collapse. Healthcare providers and patients should be familiar with the following warning signs:

  • Severe, progressive fatigue and profound weakness — disproportionate to any apparent underlying illness
  • Nausea and vomiting — often with abdominal pain, which may mimic an acute surgical abdomen
  • Hypotension and tachycardia — postural dizziness progressing to frank hypotension; unresponsive to fluid resuscitation alone without glucocorticoid replacement
  • Confusion, altered consciousness, and in extreme cases, coma — reflecting cerebral hypoperfusion and hypoglycemia
  • Hyponatremia and hyperkalemia — electrolyte disturbances driven by cortisol and aldosterone deficiency (particularly pronounced in primary adrenal insufficiency)
  • Hypoglycemia — especially in children and in patients also deficient in growth hormone
  • Fever — which may represent both the precipitating infection and the inflammatory dysregulation caused by cortisol deficiency itself

Emergency Action Plan Steps

Patients with adrenal insufficiency should have a personalized emergency action plan developed with their endocrinologist. The general sequence of steps recognized in clinical guidelines is:

  1. Recognize the crisis early. If a patient with known adrenal insufficiency develops any combination of the above symptoms—particularly hypotension, vomiting, or altered consciousness—presume adrenal crisis until proven otherwise.
  2. Administer emergency hydrocortisone immediately. Do not wait for laboratory confirmation. Administer 100 mg hydrocortisone IM or IV (or 50–100 mg in children, weight-adjusted). In a community setting, use the prescribed emergency injection kit.
  3. Call emergency services (911). After administering the injection, call for emergency medical services. Inform dispatchers that the patient has adrenal insufficiency and has received hydrocortisone.
  4. Provide IV fluids if available. In a pre-hospital setting with trained personnel, isotonic saline (0.9% NaCl) should be administered to address hypovolemia.
  5. Monitor and continue treatment in hospital. Continuous IV hydrocortisone, dextrose (if hypoglycemic), fluid resuscitation, and monitoring for and treatment of the precipitating cause are the mainstays of in-hospital management.

The key principle in all crisis management is that the risk of administering an unnecessary hydrocortisone dose to a patient who turns out not to be in crisis is negligible, while the risk of withholding treatment from a patient who is genuinely in adrenal crisis is potentially fatal. When in doubt, treat.

FAQs About Steroid Stress Dosing

Does Emotional Stress Require Extra Steroids?

This is one of the most common misconceptions encountered in clinical practice. Psychological or emotional stress—such as an argument, an exam, a difficult conversation, or even a period of sustained anxiety—does not generate a cortisol demand sufficient to require a pharmacological stress dose in the vast majority of patients with adrenal insufficiency. The HPA axis response to psychological stress is typically modest and, importantly, does not approach the magnitudes seen with physical illness, surgery, or trauma. Clinical guidelines from the Endocrine Society and other major bodies do not recommend routine stress dosing for emotional or psychological stress. The practical concern is that habitual stress dosing for non-physiological triggers exposes patients to cumulative glucocorticoid excess—with attendant risks of weight gain, glucose intolerance, osteoporosis, and adrenal suppression. Patients should maintain their prescribed maintenance dose during periods of psychological stress and discuss any uncertainty with their endocrinologist.

Are There Side Effects to Stress Dosing?

When used appropriately—for the duration and magnitude genuinely required by the physiological stressor—stress dosing carries minimal side effects because the pharmacological doses administered approximate what the body itself would have produced. However, inappropriate or prolonged stress dosing beyond clinical necessity can produce adverse effects consistent with glucocorticoid excess: transient hyperglycemia (particularly important for diabetic patients, who may need insulin dose adjustments), insomnia and agitation, edema from mineralocorticoid activity (particularly with higher doses of hydrocortisone), and, with prolonged use, impaired wound healing and immunosuppression. The practical message is that stress dosing should be precisely calibrated to the level and duration of the physiological stressor, tapered back to maintenance as soon as the patient’s clinical status permits, and never used prophylactically for events that do not pose a genuine cortisol demand.